Amylyx Pharmaceuticals (AMLX) Receivables (2022 - 2025)
Amylyx Pharmaceuticals' Receivables came in at $88,000 for Q4 2025, down 80.3% from $447,000 a year earlier and down 33.3% from the prior quarter.
Powered by 
Analysis
Amylyx Pharmaceuticals (AMLX) Receivables (2022 - 2025) Analysis & Trends
Going back to Q3 2022, Amylyx Pharmaceuticals' Receivables data covers 14 quarters.
- Receivables carries a three-year compound annual growth rate of -82.1% (FY2022 to FY2025).
- Going back by year, Receivables was $447,000 in FY2024 (-98.9%), $40.05 million in FY2023 (+161.7%) and $15.31 million in FY2022.
- The Q4 2025 figure represents the lowest quarterly Receivables in data going back to Q3 2022.
- Year-over-year, Receivables has declined for seven consecutive quarters, with an average decline of 79.2% over the last eight quarters.
- The fastest year-over-year change in Receivables over five years came in Q4 2023 (growth of 161.7%), and the weakest in Q4 2024 (a decline of 98.9%).
- Business Quant data shows AMLX's Receivables at $132,000 (Q3 2025), $103,000 (Q2 2025) and $300,000 (Q1 2025) in the three quarters before Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | Amylyx Pharmaceuticals | 3.32 Bn | 3.32 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 88,000.00 |
| Sep 30, 2025 | 132,000.00 |
| Jun 30, 2025 | 103,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 447,000.00 |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 4.09 Mn |
| Mar 31, 2024 | 20.35 Mn |
| Dec 31, 2023 | 40.05 Mn |
| Sep 30, 2023 | 29.35 Mn |
| Jun 30, 2023 | 33.47 Mn |
| Mar 31, 2023 | 17.56 Mn |
| Dec 31, 2022 | 15.31 Mn |
| Sep 30, 2022 | 137,000.00 |
API Access
Amylyx Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=AMLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "AMLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=AMLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();